MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-19-0005469
Biovet Private Limited - pharma in Malur, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹248.76 Cr
▼ 10% YoY
Net profit · FY 2025
₹163.84 Cr
Net margin 65.9%
EBITDA · FY 2025
₹103.69 Cr
EBITDA margin 41.7%
Authorised capital
₹163 Cr
Registered with MCA
Paid-up capital
₹31.56 Cr
Issued & subscribed
Open charges
₹218 Cr
Satisfied ₹14.5 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
169
Provident fund records
About Biovet Private Limited
Data last updated:
Biovet Private Limited is a private limited company based in Malur, Karnataka, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 27 January 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24235KA2005PTC035491. Its GSTIN is 29AACCB7370F1ZM (Karnataka). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹163 Cr and a paid-up capital of ₹31.56 Cr. It is led by directors including Jalachari Ella (Whole-Time Director) and Sreenivasulu Kilari (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 308 3rd Phase KIADB Industrial Area, Malur, Karnataka, India – 563130.
As per the financials filed for FY 2025, the company reported a revenue of ₹248.76 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹163.84 Cr (net margin 65.9%) and EBITDA of ₹103.69 Cr (EBITDA margin 41.7%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years and 17% over five years.
The company has about 169 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Biovet. As per MCA filings, the company has open charges of ₹218 Cr and satisfied charges of ₹14.5 Cr on record. Court records list 40 cases involving the company, including 18 filed by the company and 22 filed against it; 8 cases are pending. The company has 18 deals on record (12 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹146.98 Cr; the latest was in February 2024. Its 8 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Indian Herbs Specialities Private Limited with revenue of ₹315.14 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2021, listing 25 overdue payments to 15 micro and small suppliers.
Biovet Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-19-0005469). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biovet.in.
Company details
CIN U24235KA2005PTC035491
Registration Number 035491
Incorporation Date 27 January 2005
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-19-0005469
Key People
Jalachari Ella Whole-Time Director Sreenivasulu Kilari Whole-Time Director Raches Virendradev Ella Director Recognitions & Rankings of Biovet
Contact details
Biovet Private Limited's registered office is in Malur, Karnataka. Its website is biovet.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address308 3rd Phase KIADB Industrial Area, Malur, Karnataka, India – 563130
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Biovet Private Limited, buy the company report.
Comprehensive company report
Biovet Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Biovet is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Biovet Private Limited, buy the company report.
Financials of Biovet Private Limited
FY 2024 filings availableBiovet Private Limited reported revenue of ₹248.76 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹248.76 Cr ▼ 10%
Net profit · FY 2025
₹163.84 Cr margin 65.9%
EBITDA · FY 2025
₹103.69 Cr margin 41.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 50%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▼ 61%
5 years · compounded
▲ 18%
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹103.69 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹163.84 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 41.7% | ||||
| Net Profit Margin | 65.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biovet Private Limited, buy the company report.
Board of directors of Biovet Private Limited
Biovet has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jalachari Ella Also directs: Skegen Asset Management LLP, Ella Fresh Private Limited, Ella Foods Private Limited and 4 more | Whole-Time Director | 06 Sep 2019 | 7 Years 1 Months | Current |
| Raches Virendradev Ella Also directs: Ella Fresh Private Limited, Ella Foods Private Limited, Sapigen Biologix Private Limited and 4 more | Director | 06 Sep 2019 | 7 Years 1 Months | Current |
| Sreenivasulu Kilari | Whole-Time Director | 04 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Biovet Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indian Herbs Specialities Private Limited | ₹315.14 Cr (FY 2025) | 5.0% | Saharanpur, Uttar Pradesh, India | |||
| Hester Biosciences Limited | ₹315.03 Cr (FY 2025) | 0.0% | Mehsana, Gujarat, India | |||
| Sava Healthcare Limited | ₹284.97 Cr (FY 2025) | 14.0% | Wadhwan, Gujarat, India | |||
| Biovet Private Limitedthis company | ₹248.76 Cr (FY 2025) | ₹163.84 Cr | 65.9% | -10.0% | 169 | Malur, Karnataka, India |
| Neospark Drugs and Chemicals Private Limited. | ₹228.21 Cr (FY 2025) | 17.0% | Telangana, India | |||
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | -29.0% | Mumbai, Maharashtra, India | |||
| Ashish Life Science Private Limited | ₹214.76 Cr (FY 2025) | 15.0% | Palghar, Maharashtra, India | |||
| Unique Biotech Limited | ₹198.58 Cr (FY 2024) | 16.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Biovet Private Limited, buy the company report.
Auditor
Biovet Private Limited is audited by MURALI & VENKAT for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MURALI & VENKAT | FY 2023 | 002162S |
Shareholding
The shareholding of Biovet Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biovet Private Limited, buy the company report.
Charges & borrowings
Open charges
₹218 Cr
Satisfied charges
₹14.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 May 2007 | 10054540 | State Bank of India | ₹218 Cr | Open | |
| 28 Jun 2006 | 10026547 | Technology Development Board | ₹14.5 Cr | Satisfied |
To see the full charge records of Biovet Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Biovet Private Limited has 18 deals on record (12 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹146.98 Cr; the latest was in February 2024.
Total deals
18
Secondary share transfers
12
Funding rounds
4
Rights issue
1
Acquisition
1
Disclosed funding
₹146.98 Cr
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2021 | Secondary share transfer | Undisclosed | Seller: Bharat Biotech International Limited |
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: RCC Laboratories India Private Limited Seller: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Century Biologicals Private Limited , an individual |
| May 2015 | Rights issue | ₹14.87 Cr | Investors: Century Biologicals Private Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: Century Biologicals Private Limited Seller: an individual |
To see the full deal history of Biovet Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Biovet Private Limited has 40 court cases on record: 18 filed by Biovet, 22 filed against it. 8 cases are pending and 32 are disposed.
Total cases
40
Filed by the company
18
Filed against the company
22
Pending
8
Disposed
32
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 20 | 12 | 4 |
| District courts | 18 | 10 | 4 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 40)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.O.S.) | Filed against the company by M/S Interarch Building Products Ltd | Pending |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against M/S Intervet India Pvt. Ltd. and 8 others | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Machinfabrik | Pending |
| High Court of Karnataka | Court case (COP) | Filed against the company by Himedia Laboratories Private Limited | Disposed |
| High Court of Karnataka | Appeal | Filed against the company by Concorde Health Care Pvt Ltd | Disposed |
To see the full case history of Biovet Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Biovet Private Limited was last rated by Indiarating on 27 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Indiarating | 27 Oct 2021 |
To see the full credit ratings and regulatory alerts of Biovet Private Limited, buy the company report.
MSME payment delays
Biovet Private Limited has 5 MSME Form 1 returns on record between 2019 and 2021, listing 25 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Climate Changers - Technology Solutions Private Limited | |||
| an individual supplier | |||
| Pharmalab India Private Limited. | |||
| Spec & Cal Gases Private Limited | |||
| Sukrut Uv Systems Private Limited |
To see the full MSME payment records of Biovet Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Biovet has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Biovet Private Limited has a workforce of 169 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
169
Active EPFO establishments
1
Employee growth
13.42%
GST
Biovet has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCB7370F1ZM | Karnataka | Active | 01 Jul 2017 |
| 29AACCB7370F2ZL | Karnataka | Active | 01 Apr 2025 |
| 27AACCB7370F1ZQ | Maharashtra | Active | 02 Jun 2021 |
To see the full GST registrations and return filing status of Biovet Private Limited, buy the company report.
Recent activity
Biovet Private Limited has 12 board changes on record since 2010: 3 appointments and 9 cessations. The latest: Narayanaiah Sainath Sreenath ceased to be CEO on 29 Jul 2025.
AGM
Biovet Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Narayanaiah Sainath Sreenath ceased to be CEO.
Filing
Biovet Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Charges
A charge with State Bank Of India of Rs. 218.00 Cr registered on 11 May 2007 with Charge ID 10054540 was modified on 21 Nov 2023.
Ceased
Santhosh Kumar Gunemoni ceased to be Company Secretary.
Appointed
Sreenivasulu Kilari was appointed as Whole-Time Director.
Ceased
Shree Narayan Singh ceased to be Director.
Ceased
Yogeswara Rao Danda ceased to be Director.
Ceased
Raches Virendradev Ella ceased to be Director.
Ceased
Jalachari Ella ceased to be Additional Director.
Ceased
Srinivas Tadepally ceased to be Director.
Appointed
Jalachari Ella was appointed as Whole-Time Director.
8 earlier events are in the company report.
News
Frequently asked questions
Biovet is an active private limited company based in Malur, Karnataka, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 27 January 2005 (21+ years old) and is registered under CIN U24235KA2005PTC035491.
Biovet has 3 current directors:
- Jalachari Ella - Whole-Time Director
- Sreenivasulu Kilari - Whole-Time Director
- Raches Virendradev Ella - Director
The latest financial statements of Biovet on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biovet is 29AACCB7370F1ZM, registered in Karnataka. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 29AACCB7370F2ZL (Karnataka), 27AACCB7370F1ZQ (Maharashtra).
The CIN (Corporate Identification Number) of Biovet is U24235KA2005PTC035491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biovet has 40 court cases on record: 18 filed by the company and 22 filed against it. 8 are pending. Most are in the high courts.
Biovet was incorporated on 27 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Bangalore.
Biovet has 18 deals on record (12 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹146.98 Cr; the latest was in February 2024.
The peers of Biovet by revenue are Indian Herbs Specialities Private Limited, Hester Biosciences Limited, Sava Healthcare Limited, Neospark Drugs and Chemicals Private Limited, Salvi Chemical Industries Limited and 3 more, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Narayanaiah Sainath Sreenath ceased to be CEO on 29 Jul 2025. Santhosh Kumar Gunemoni ceased to be Company Secretary on 01 Sep 2023. Sreenivasulu Kilari was appointed as Whole-Time Director on 04 Feb 2022. Biovet has 12 board changes on record in total.
Yes, Biovet is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-19-0005469).
Biovet has 5 MSME Form 1 returns on record between 2019 and 2021, listing 25 overdue payments to 15 micro and small suppliers. The latest return was filed on 11 May 2021.